And post-transcriptional gene expression. The p38 MAPK pathway activation in inflammation

Материал из wiki-veloguide
Перейти к: навигация, поиск

The MK2-knockout mice with induced collagen arthritis exhibit decreased disease incidence and severity, Ng inflammatory response, a lot of signaling pathways are dormant, but become transiently related with reduced TNF-a and IL-.And post-transcriptional gene expression. The p38 MAPK pathway activation in inflammation is among the most typical pathways that regulate mRNA stability in numerous cell types. This pathway is central to the stabilization of numerous ARE-mRNA involved in inflammation and cancer, which includes COX-2, TNF-a, IL-3, IL-6, IL-8, macrophage inhibitory protein 1 (MIP1), GM-CSF, VEGF, c-fos, and uPA [69, 111?16]. The pro-inflammatory cytokines, IL-1a and TNF-a, have already been found to stabilize a significant number of cytokines and chemokines which includes CXCL-10 (IP-10), GRO proteins, and fractalkine (SCYD1), and many genes involved in regulation of inflammatory responses such as TNFAIP3, NFjBaI, and mannose-binding lectin (MBL2) [117?19].stressTLPIPPAKTPIPPPTENKTPIKKNF BPSTATP PPPIBP P PPTTPP P PPKSRP PP P P PBRF1PAUFNF BStabilization of ARE-mRNA*Tcf/ lefNF BFig. 2 Prevalent signaling pathways in inflammation and cancer including those regulating ARE-gene expression and mRNA stability. Microbial stimuli, inflammatory and tumor inducers, and ARE-gene items themselves like specific growth factors and pro-inflammatory cytokines trigger many signaling pathways. One of these would be the p38 MAPK pathway that results in phosphorylation and inactivation in the activity on the RNA decay-promoting proteins suchas TTP and KSRP. This final results in stabilization of ARE-mRNAs that happen to be involved in chronic inflammation and cancer. The RNA-binding stabilizing protein, HuR, is in a position to compete with the RNA-binding proteins title= s00221-011-2677-0 which include TTP and AUF1 for exactly the same mRNA targets; even so, it may also act independently on mRNA targets for promoting mRNA stabilizationS ATAU-rich components in inflammation and cancerThese cytokines and lots of other people are regulated by the p38 MAPK signaling and its target, MK2, to trigger the AREmRNA stabilization. Not all ARE-mRNAs, irrespective of the ARE class, are targets for the MAPK p38 pathway [37]. As a result, the p38 MAPK pathway isn't essential for all AREmRNAs and seems to be also dependent around the stimulus. Cooperative action of p38 MAPK and ERK pathways might be necessary for optimal ARE-mRNA stabilization, particularly within the case of inhibition of TTP [120]. Another p38 MAPK downstream target with structural and functional similarity to MK2 is MK3; it really is thought to cooperate with MK2 in TNF-a mRNA stabilization [121]. Effect of p38 MAPK on TTP and HuR functions Activation with the p38 MAPK pathway leads to MK2mediated phosphorylation of TTP and KSRP major to loss of function of these RNA-binding proteins, e.g., lowered affinity to ARE regions, and subsequently AREmRNA stabilization (Fig. 2) [122?24]. A detailed part for MK2 is demonstrated, for instance, in the stability of IL-8 mRNA because mutants of MK2 interfere with IL-8 mRNA stability [116]. Selective activation in the p38 MAPK pathway by MAPK kinase 6 induces mRNA stabilization of IL-8 [112]. MK2 can regulate IL-6 in the levels of mRNA stability, and of TNF-a mostly through TNF-AREdependent translational control [125]. In vitro evidence shows that TTP might be straight phosphorylated by either p38 or MK2 potentially modifying mRNA destabilizing activity of TTP [121, 122].